| Schedule of company's other receivable balance |
| | | | | | | | | June 30, | | December 31, | | | 2026 | | 2025 | Grant income receivable: | | | | | | | CPRIT AML Grant | | $ | 1,311,557 | | $ | 815,436 | FDA Grant | | | 20,055 | | | 3,678 | SBIR AML Grant | | | — | | | 162,897 | Decoy Grant | | | 141,900 | | | 59,501 | SBIR NHL Grant | | | — | | | 87,417 | PANACEA Grant | | | 105,601 | | | 190,052 | Total grant income receivable | | | 1,579,113 | | | 1,318,981 | Interest receivable | | | 33,161 | | | 50,419 | Other | | | 7,203 | | | — | Total other receivable | | $ | 1,619,477 | | $ | 1,369,400 |
|